share_log

Citigroup Downgrades Cano Health to Neutral, Lowers Price Target to $0.8

Benzinga ·  Aug 11, 2023 17:36

Citigroup analyst Jason Cassorla downgrades Cano Health (NYSE:CANO) from Buy to Neutral and lowers the price target from $4 to $0.8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment